Nucleophilic covalent ligand discovery for the cysteine redoxome.


Journal

Nature chemical biology
ISSN: 1552-4469
Titre abrégé: Nat Chem Biol
Pays: United States
ID NLM: 101231976

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 16 06 2022
accepted: 07 04 2023
medline: 30 10 2023
pubmed: 30 5 2023
entrez: 29 5 2023
Statut: ppublish

Résumé

With an eye toward expanding chemistries used for covalent ligand discovery, we elaborated an umpolung strategy that exploits the 'polarity reversal' of sulfur when cysteine is oxidized to sulfenic acid, a widespread post-translational modification, for selective bioconjugation with C-nucleophiles. Here we present a global map of a human sulfenome that is susceptible to covalent modification by members of a nucleophilic fragment library. More than 500 liganded sulfenic acids were identified on proteins across diverse functional classes, and, of these, more than 80% were not targeted by electrophilic fragment analogs. We further show that members of our nucleophilic fragment library can impair functional protein-protein interactions involved in nuclear oncoprotein transport and DNA damage repair. Our findings reveal a vast expanse of ligandable sulfenic acids in the human proteome and highlight the utility of nucleophilic small molecules in the fragment-based covalent ligand discovery pipeline, presaging further opportunities using non-traditional chemistries for targeting proteins.

Identifiants

pubmed: 37248412
doi: 10.1038/s41589-023-01330-5
pii: 10.1038/s41589-023-01330-5
doi:

Substances chimiques

Cysteine K848JZ4886
Ligands 0
Sulfenic Acids 0
Proteome 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1309-1319

Subventions

Organisme : U.S. Department of Health & Human Services | National Institutes of Health (NIH)
ID : GM102187
Organisme : U.S. Department of Health & Human Services | National Institutes of Health (NIH)
ID : GM087638
Organisme : National Natural Science Foundation of China (National Science Foundation of China)
ID : 21922702

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Nature America, Inc.

Références

Singh, J., Petter, R. C., Baillie, T. A. & Whitty, A. The resurgence of covalent drugs. Nat. Rev. Drug Discov. 10, 307–317 (2011).
pubmed: 21455239
Békés, M., Langley, D. R. & Crews, C. M. PROTAC targeted protein degraders: the past is prologue. Nat. Rev. Drug Discov. 21, 181–200 (2022).
pubmed: 35042991 pmcid: 8765495
Lu, W. et al. Fragment-based covalent ligand discovery. RSC Chem. Biol. 2, 354–367 (2021).
pubmed: 34458789 pmcid: 8341086
Zhang, T., Hatcher, J. M., Teng, M., Gray, N. S. & Kostic, M. Recent advances in selective and irreversible covalent ligand development and validation. Cell Chem. Biol. 26, 1486–1500 (2019).
pubmed: 31631011 pmcid: 6886688
Singh, J. The ascension of targeted covalent inhibitors. J. Med. Chem. 65, 5886–5901 (2022).
pubmed: 35439421
Li, D. et al. BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models. Oncogene 27, 4702–4711 (2008).
pubmed: 18408761 pmcid: 2748240
Skoulidis, F. et al. Sotorasib for lung cancers with KRAS p.G12C mutation. N. Engl. J. Med. 384, 2371–2381 (2021).
pubmed: 34096690 pmcid: 9116274
Nomura, D. K., Dix, M. M. & Cravatt, B. F. Activity-based protein profiling for biochemical pathway discovery in cancer. Nat. Rev. Cancer 10, 630–638 (2010).
pubmed: 20703252 pmcid: 3021511
Backus, K. M. et al. Proteome-wide covalent ligand discovery in native biological systems. Nature 534, 570–574 (2016).
pubmed: 27309814 pmcid: 4919207
Parker, C. G. et al. Ligand and target discovery by fragment-based screening in human cells. Cell 168, 527–541 (2017).
pubmed: 28111073 pmcid: 5632530
Paulsen, C. E. & Carroll, K. S. Cysteine-mediated redox signaling: chemistry, biology, and tools for discovery. Chem. Rev. 113, 4633–4679 (2013).
pubmed: 23514336 pmcid: 4303468
Shi, Y. & Carroll, K. S. Activity-based sensing for site-specific proteomic analysis of cysteine oxidation. Acc. Chem. Res. 53, 20–31 (2020).
pubmed: 31869209
Meng, J. et al. Global profiling of distinct cysteine redox forms reveals wide-ranging redox regulation in C. elegans. Nat. Commun. 12, 1415 (2021).
pubmed: 33658510 pmcid: 7930113
Yang, J., Gupta, V., Carroll, K. S. & Liebler, D. C. Site-specific mapping and quantification of protein S-sulphenylation in cells. Nat. Commun. 5, 4776 (2014).
pubmed: 25175731
Shi, Y., Fu, L., Yang, J. & Carroll, K. S. Wittig reagents for chemoselective sulfenic acid ligation enables global site stoichiometry analysis and redox-controlled mitochondrial targeting. Nat. Chem. 13, 1140–1150 (2021).
pubmed: 34531572 pmcid: 9121980
Truong, T. H. T. H. T. H. et al. Molecular basis for redox activation of epidermal growth factor receptor kinase. Cell Chem. Biol. 23, 837–848 (2016).
pubmed: 27427230 pmcid: 4958504
Paulsen, C. E. et al. Peroxide-dependent sulfenylation of the EGFR catalytic site enhances kinase activity. Nat. Chem. Biol. 8, 57–64 (2012).
Salmeen, A. et al. Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate. Nature 423, 769–773 (2003).
pubmed: 12802338
Chiu, J. & Hogg, P. J. Allosteric disulfides: sophisticated molecular structures enabling flexible protein regulation. J. Biol. Chem. 294, 2949–2960 (2019).
pubmed: 30635401 pmcid: 6393624
Gupta, V. & Carroll, K. S. Sulfenic acid chemistry, detection and cellular lifetime. Biochim. Biophys. Acta 1840, 847–875 (2014).
pubmed: 23748139
Reisz, J. A., Bechtold, E., King, S. B., Poole, L. B. & Furdui, C. M. Thiol-blocking electrophiles interfere with labeling and detection of protein sulfenic acids. FEBS J. 280, 6150–6161 (2013).
pubmed: 24103186 pmcid: 3928805
Forman, H. J. & Zhang, H. Targeting oxidative stress in disease: promise and limitations of antioxidant therapy. Nat. Rev. Drug Discov. 20, 689–709 (2021).
pubmed: 34194012 pmcid: 8243062
Huynh, M. V. et al. Oncogenic KRAS G12C: kinetic and redox characterization of covalent inhibition. J. Biol. Chem. 298, 102186 (2022).
pubmed: 35753348 pmcid: 9352912
Leonard, S. E., Garcia, F. J., Goodsell, D. S. & Carroll, K. S. Redox-based probes for protein tyrosine phosphatases. Angew. Chem. Int. Ed. Engl. 50, 4423–4427 (2011).
pubmed: 21504031
Garcia, F. J. & Carroll, K. S. Redox-based probes as tools to monitor oxidized protein tyrosine phosphatases in living cells. Eur. J. Med. Chem. 88, 28–33 (2014).
pubmed: 24974258
Gupta, V., Yang, J., Liebler, D. C. & Carroll, K. S. Diverse redoxome reactivity profiles of carbon nucleophiles. J. Am. Chem. Soc. 139, 5588–5595 (2017).
pubmed: 28355876 pmcid: 5898444
Fu, L., Liu, K., Ferreira, R. B., Carroll, K. S. & Yang, J. Proteome-wide analysis of cysteine S-sulfenylation using a benzothiazine-based probe. Curr. Protoc. Protein Sci. 95, e76 (2019).
pubmed: 30312022
Shi, Y. & Carroll, K. S. Parallel evaluation of nucleophilic and electrophilic chemical probes for sulfenic acid: reactivity, selectivity and biocompatibility. Redox Biol. 46, 102072 (2021).
pubmed: 34298464 pmcid: 8321940
Weerapana, E. et al. Quantitative reactivity profiling predicts functional cysteines in proteomes. Nature 468, 790–795 (2010).
pubmed: 21085121 pmcid: 3058684
Abbasov, M. E. et al. A proteome-wide atlas of lysine-reactive chemistry. Nat. Chem. 13, 1081–1092 (2021).
pubmed: 34504315 pmcid: 8952960
Bateman, A. et al. UniProt: the universal protein knowledgebase in 2021. Nucleic Acids Res. 49, D480–D489 (2021).
Akter, S. et al. Chemical proteomics reveals new targets of cysteine sulfinic acid reductase. Nat. Chem. Biol. 14, 995–1004 (2018).
pubmed: 30177848 pmcid: 6192846
Petri, L. et al. An electrophilic warhead library for mapping the reactivity and accessibility of tractable cysteines in protein kinases. Eur. J. Med. Chem. 207, 112836 (2020).
pubmed: 32971426
Gupta, V. & Carroll, K. S. Rational design of reversible and irreversible cysteine sulfenic acid-targeted linear C-nucleophiles. Chem. Commun. 52, 3414–3417 (2016).
Gupta, V. & Carroll, K. S. Profiling the reactivity of cyclic C-nucleophiles towards electrophilic sulfur in cysteine sulfenic acid. Chem. Sci. 7, 400–415 (2016).
pubmed: 26819701
Gupta, V., Paritala, H. & Carroll, K. S. Reactivity, selectivity, and stability in sulfenic acid detection: a comparative study of nucleophilic and electrophilic probes. Bioconjug. Chem. 27, 1411–1418 (2016).
pubmed: 27123991 pmcid: 4886738
Fu, L. et al. A quantitative thiol reactivity profiling platform to analyze redox and electrophile reactive cysteine proteomes. Nat. Protoc. 15, 2891–2919 (2020).
pubmed: 32690958
Crowley, V. M., Thielert, M. & Cravatt, B. F. Functionalized scout fragments for site-specific covalent ligand discovery and optimization. ACS Cent. Sci. 7, 613–623 (2021).
pubmed: 34056091 pmcid: 8155467
Wishart, D. S. et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 46, D1074–D1082 (2018).
pubmed: 29126136
Peralta, D. et al. A proton relay enhances H
pubmed: 25580853
Chen, Y. F. et al. miR-125b suppresses oral oncogenicity by targeting the anti-oxidative gene PRXL2A. Redox Biol. 22, 101140 (2019).
pubmed: 30785086 pmcid: 6383183
Bao, C., Wang, J., Ma, W., Wang, X. & Cheng, Y. HDGF: a novel jack-of-all-trades in cancer. Future Oncol. 10, 2675–2685 (2014).
pubmed: 25236340
Bremer, S. et al. Hepatoma-derived growth factor and nucleolin exist in the same ribonucleoprotein complex. BMC Biochem. 14, 2 (2013).
pubmed: 23305559 pmcid: 3551658
Shin, S. H. et al. Aberrant expression of CITED2 promotes prostate cancer metastasis by activating the nucleolin-AKT pathway. Nat. Commun. 9, 4113 (2018).
pubmed: 30291252 pmcid: 6173745
Lu, H., Yue, J., Meng, X., Nickoloff, J. A. & Shen, Z. BCCIP regulates homologous recombination by distinct domains and suppresses spontaneous DNA damage. Nucleic Acids Res. 35, 7160–7170 (2007).
pubmed: 17947333 pmcid: 2175368
Haque, A., Andersen, J. N., Salmeen, A., Barford, D. & Tonks, N. K. Conformation-sensing antibodies stabilize the oxidized form of PTP1B and inhibit its phosphatase activity. Cell 147, 185–198 (2011).
pubmed: 21962515 pmcid: 3200309
Parvez, S. et al. Substoichiometric hydroxynonenylation of a single protein recapitulates whole-cell-stimulated antioxidant response. J. Am. Chem. Soc. 137, 10–13 (2015).
pubmed: 25544059
Su, Z. et al. Global redox proteome and phosphoproteome analysis reveals redox switch in Akt. Nat. Commun. 10, 5486 (2019).
pubmed: 31792197 pmcid: 6889415
Wang, X. et al. Discovery of potent and selective inhibitors against protein-derived electrophilic cofactors. J. Am. Chem. Soc. 144, 5377–5388 (2022).
pubmed: 35235319 pmcid: 10159212
Zhang, H. et al. A cell cycle-dependent BRCA1–UHRF1 cascade regulates DNA double-strand break repair pathway choice. Nat. Commun. 7, 10201 (2016).
pubmed: 26727879 pmcid: 4728409

Auteurs

Ling Fu (L)

State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences-Beijing, Beijing Institute of Lifeomics, Beijing, China.

Youngeun Jung (Y)

Department of Chemistry, UF Scripps Biomedical Research, Jupiter, FL, USA.

Caiping Tian (C)

State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences-Beijing, Beijing Institute of Lifeomics, Beijing, China.
School of Medicine, Tsinghua University, Beijing, China.

Renan B Ferreira (RB)

Department of Chemistry, UF Scripps Biomedical Research, Jupiter, FL, USA.

Ruifeng Cheng (R)

State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences-Beijing, Beijing Institute of Lifeomics, Beijing, China.
School of Basic Medical Sciences, Anhui Medical University, Hefei, China.

Fuchu He (F)

State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences-Beijing, Beijing Institute of Lifeomics, Beijing, China.
School of Medicine, Tsinghua University, Beijing, China.

Jing Yang (J)

State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences-Beijing, Beijing Institute of Lifeomics, Beijing, China. yangjing@ncpsb.org.cn.

Kate S Carroll (KS)

Department of Chemistry, UF Scripps Biomedical Research, Jupiter, FL, USA. kate.carroll@ufl.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH